Coya Therapeutics’ (COYA) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Free Report) in a report issued on Tuesday,Benzinga reports. They currently have a $18.00 target price on the stock. Separately, Chardan Capital reaffirmed a “buy” rating and set a $14.00 price target on shares of Coya Therapeutics in a research report […]
D. Boral Capital reaffirmed their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Free Report) in a report issued on Tuesday,Benzinga reports. They currently have a $18.00 target price on the stock. Separately, Chardan Capital reaffirmed a “buy” rating and set a $14.00 price target on shares of Coya Therapeutics in a research report […]